Connection

Ann-Charlotte Bentley to Disease Models, Animal

This is a "connection" page, showing publications Ann-Charlotte Bentley has written about Disease Models, Animal.
Connection Strength

0.514
  1. A dual-hit animal model for age-related parkinsonism. Prog Neurobiol. 2010 Feb 09; 90(2):217-29.
    View in: PubMed
    Score: 0.194
  2. Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol. 2011 May; 21(3):330-48.
    View in: PubMed
    Score: 0.052
  3. Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res. 2008 Nov 19; 1241:18-28.
    View in: PubMed
    Score: 0.045
  4. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets. 2004 Aug; 5(6):517-28.
    View in: PubMed
    Score: 0.034
  5. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav Brain Res. 2003 Feb 17; 139(1-2):47-57.
    View in: PubMed
    Score: 0.031
  6. Why do we need to use animal models to study cognition and aging? Neuropsychopharmacology. 2010 Jul; 35(8):1621-2.
    View in: PubMed
    Score: 0.025
  7. BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson?s disease. Brain Res. 2016 Jan 15; 1631:34-45.
    View in: PubMed
    Score: 0.018
  8. Designer receptors enhance memory in a mouse model of Down syndrome. J Neurosci. 2015 Jan 28; 35(4):1343-53.
    View in: PubMed
    Score: 0.017
  9. Down syndrome and Alzheimer's disease: Common pathways, common goals. Alzheimers Dement. 2015 Jun; 11(6):700-9.
    View in: PubMed
    Score: 0.017
  10. Three-dimensional rodent motion analysis and neurodegenerative disorders. J Neurosci Methods. 2014 Jul 15; 231:31-7.
    View in: PubMed
    Score: 0.016
  11. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus. 2003; 13(8):905-14.
    View in: PubMed
    Score: 0.015
  12. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res. 2011 Aug 10; 221(2):610-22.
    View in: PubMed
    Score: 0.012
  13. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol. 2009 Apr; 216(2):278-89.
    View in: PubMed
    Score: 0.011
  14. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann Neurol. 2004 Nov; 56(5):675-88.
    View in: PubMed
    Score: 0.009
  15. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol Aging. 2004 Aug; 25(7):873-84.
    View in: PubMed
    Score: 0.008
  16. Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur J Neurosci. 2004 Jun; 19(12):3305-16.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.